Loading…
Synthesis of 2‑Pyridyl-benzimidazole Iridium(III), Ruthenium(II), and Platinum(II) Complexes. Study of the Activity as Inhibitors of Amyloid‑β Aggregation and Neurotoxicity Evaluation
The design of small molecules that can target the aggregation of Aβ as potential therapeutic agents for Alzheimer’s disease is an area of study that has attracted a lot of attention recently. The novel ligand methyl 1-butyl-2-pyridyl-benzimidazole carboxylate was prepared for the synthesis of a seri...
Saved in:
Published in: | Inorganic chemistry 2015-01, Vol.54 (2), p.470-475 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-a381t-ab0002bf3e0b3e5ab18bb6eab16fdab43f88684ccb054fd503ba4f0a7c836dee3 |
---|---|
cites | cdi_FETCH-LOGICAL-a381t-ab0002bf3e0b3e5ab18bb6eab16fdab43f88684ccb054fd503ba4f0a7c836dee3 |
container_end_page | 475 |
container_issue | 2 |
container_start_page | 470 |
container_title | Inorganic chemistry |
container_volume | 54 |
creator | Yellol, Gorakh S Yellol, Jyoti G Kenche, Vijaya B Liu, Xiang Ming Barnham, Kevin J Donaire, Antonio Janiak, Christoph Ruiz, José |
description | The design of small molecules that can target the aggregation of Aβ as potential therapeutic agents for Alzheimer’s disease is an area of study that has attracted a lot of attention recently. The novel ligand methyl 1-butyl-2-pyridyl-benzimidazole carboxylate was prepared for the synthesis of a series of new iridium(III), ruthenium(II), and platinum(II) 2-pyridyl-benzimidazole complexes. The crystal structure of the half-sandwich iridium(III) complex was established by X-ray diffraction. An arrangement of two cationic complexes in the unit cell is observed, and it seems to be organized by weak π···π interactions that are taking place between two symmetry-related benzimidazole ring systems. All new compounds inhibited aggregation of Aβ1–42 in vitro as shown by both thioflavin T fluorescence assay and transmission electron microscopy. Among them the Ir compound rescued the toxicity of Aβ1–42 in primary cortical neurons effectively. |
doi_str_mv | 10.1021/ic502119b |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1872828735</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1793260447</sourcerecordid><originalsourceid>FETCH-LOGICAL-a381t-ab0002bf3e0b3e5ab18bb6eab16fdab43f88684ccb054fd503ba4f0a7c836dee3</originalsourceid><addsrcrecordid>eNqFkU9u1DAUxi0EokNhwQWQN0itRIodO_-Wo1Ghkaq2oiCxi-z4ZeoqsQc7rpquuAJX6ZozcAhOgmdSukJi9fk9_973ZH8IvabkiJKUvtdtFoVW8gla0CwlSUbJ16doQUg80zyv9tAL768JIRXj-XO0l2acVLxKF-jn5WTGK_DaY9vh9Pf3HxeT02rqEwnmTg9aiTvbA65jU4fhoK7rw3f4U4gzZq5jKYzCF70YtZk7eGWHTQ-34I_w5RjUtPWOE3jZjvpGjxMWHtfmSks9WrfbvBym3moV9_-6x8v12sE6-lmz8z6D4Oxob3W7nT2-EX3YXb5EzzrRe3j1oPvoy4fjz6uT5PT8Y71aniaClXRMhIwvT2XHgEgGmZC0lDKHqHmnhOSsK8u85G0rScY7lREmBe-IKNqS5QqA7aOD2Xfj7LcAfmwG7Vvoe2HABt_QskjLtCxY9n-0qFiaE86LiB7OaOus9w66ZuP0INzUUNJsc20ec43smwfbIAdQj-TfICPwdgZE65trG5yJH_IPoz9kt677</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1793260447</pqid></control><display><type>article</type><title>Synthesis of 2‑Pyridyl-benzimidazole Iridium(III), Ruthenium(II), and Platinum(II) Complexes. Study of the Activity as Inhibitors of Amyloid‑β Aggregation and Neurotoxicity Evaluation</title><source>American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list)</source><creator>Yellol, Gorakh S ; Yellol, Jyoti G ; Kenche, Vijaya B ; Liu, Xiang Ming ; Barnham, Kevin J ; Donaire, Antonio ; Janiak, Christoph ; Ruiz, José</creator><creatorcontrib>Yellol, Gorakh S ; Yellol, Jyoti G ; Kenche, Vijaya B ; Liu, Xiang Ming ; Barnham, Kevin J ; Donaire, Antonio ; Janiak, Christoph ; Ruiz, José</creatorcontrib><description>The design of small molecules that can target the aggregation of Aβ as potential therapeutic agents for Alzheimer’s disease is an area of study that has attracted a lot of attention recently. The novel ligand methyl 1-butyl-2-pyridyl-benzimidazole carboxylate was prepared for the synthesis of a series of new iridium(III), ruthenium(II), and platinum(II) 2-pyridyl-benzimidazole complexes. The crystal structure of the half-sandwich iridium(III) complex was established by X-ray diffraction. An arrangement of two cationic complexes in the unit cell is observed, and it seems to be organized by weak π···π interactions that are taking place between two symmetry-related benzimidazole ring systems. All new compounds inhibited aggregation of Aβ1–42 in vitro as shown by both thioflavin T fluorescence assay and transmission electron microscopy. Among them the Ir compound rescued the toxicity of Aβ1–42 in primary cortical neurons effectively.</description><identifier>ISSN: 0020-1669</identifier><identifier>EISSN: 1520-510X</identifier><identifier>DOI: 10.1021/ic502119b</identifier><identifier>PMID: 25409492</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Agglomeration ; Amyloid beta-Peptides - chemistry ; Amyloid beta-Peptides - toxicity ; Animals ; Benzimidazoles - chemistry ; Cationic ; Chemistry Techniques, Synthetic ; Design analysis ; Diffraction ; Drug Design ; Female ; Fluorescence ; Iridium - chemistry ; Ligands ; Mice ; Models, Molecular ; Molecular Conformation ; Neurons - cytology ; Neurons - drug effects ; Organometallic Compounds - chemical synthesis ; Organometallic Compounds - chemistry ; Organometallic Compounds - pharmacology ; Peptide Fragments - chemistry ; Peptide Fragments - toxicity ; Platinum - chemistry ; Pregnancy ; Protein Multimerization - drug effects ; Protein Structure, Secondary ; Ruthenium - chemistry ; Synthesis ; Toxicity ; Unit cell</subject><ispartof>Inorganic chemistry, 2015-01, Vol.54 (2), p.470-475</ispartof><rights>Copyright © 2014 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a381t-ab0002bf3e0b3e5ab18bb6eab16fdab43f88684ccb054fd503ba4f0a7c836dee3</citedby><cites>FETCH-LOGICAL-a381t-ab0002bf3e0b3e5ab18bb6eab16fdab43f88684ccb054fd503ba4f0a7c836dee3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25409492$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yellol, Gorakh S</creatorcontrib><creatorcontrib>Yellol, Jyoti G</creatorcontrib><creatorcontrib>Kenche, Vijaya B</creatorcontrib><creatorcontrib>Liu, Xiang Ming</creatorcontrib><creatorcontrib>Barnham, Kevin J</creatorcontrib><creatorcontrib>Donaire, Antonio</creatorcontrib><creatorcontrib>Janiak, Christoph</creatorcontrib><creatorcontrib>Ruiz, José</creatorcontrib><title>Synthesis of 2‑Pyridyl-benzimidazole Iridium(III), Ruthenium(II), and Platinum(II) Complexes. Study of the Activity as Inhibitors of Amyloid‑β Aggregation and Neurotoxicity Evaluation</title><title>Inorganic chemistry</title><addtitle>Inorg. Chem</addtitle><description>The design of small molecules that can target the aggregation of Aβ as potential therapeutic agents for Alzheimer’s disease is an area of study that has attracted a lot of attention recently. The novel ligand methyl 1-butyl-2-pyridyl-benzimidazole carboxylate was prepared for the synthesis of a series of new iridium(III), ruthenium(II), and platinum(II) 2-pyridyl-benzimidazole complexes. The crystal structure of the half-sandwich iridium(III) complex was established by X-ray diffraction. An arrangement of two cationic complexes in the unit cell is observed, and it seems to be organized by weak π···π interactions that are taking place between two symmetry-related benzimidazole ring systems. All new compounds inhibited aggregation of Aβ1–42 in vitro as shown by both thioflavin T fluorescence assay and transmission electron microscopy. Among them the Ir compound rescued the toxicity of Aβ1–42 in primary cortical neurons effectively.</description><subject>Agglomeration</subject><subject>Amyloid beta-Peptides - chemistry</subject><subject>Amyloid beta-Peptides - toxicity</subject><subject>Animals</subject><subject>Benzimidazoles - chemistry</subject><subject>Cationic</subject><subject>Chemistry Techniques, Synthetic</subject><subject>Design analysis</subject><subject>Diffraction</subject><subject>Drug Design</subject><subject>Female</subject><subject>Fluorescence</subject><subject>Iridium - chemistry</subject><subject>Ligands</subject><subject>Mice</subject><subject>Models, Molecular</subject><subject>Molecular Conformation</subject><subject>Neurons - cytology</subject><subject>Neurons - drug effects</subject><subject>Organometallic Compounds - chemical synthesis</subject><subject>Organometallic Compounds - chemistry</subject><subject>Organometallic Compounds - pharmacology</subject><subject>Peptide Fragments - chemistry</subject><subject>Peptide Fragments - toxicity</subject><subject>Platinum - chemistry</subject><subject>Pregnancy</subject><subject>Protein Multimerization - drug effects</subject><subject>Protein Structure, Secondary</subject><subject>Ruthenium - chemistry</subject><subject>Synthesis</subject><subject>Toxicity</subject><subject>Unit cell</subject><issn>0020-1669</issn><issn>1520-510X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNqFkU9u1DAUxi0EokNhwQWQN0itRIodO_-Wo1Ghkaq2oiCxi-z4ZeoqsQc7rpquuAJX6ZozcAhOgmdSukJi9fk9_973ZH8IvabkiJKUvtdtFoVW8gla0CwlSUbJ16doQUg80zyv9tAL768JIRXj-XO0l2acVLxKF-jn5WTGK_DaY9vh9Pf3HxeT02rqEwnmTg9aiTvbA65jU4fhoK7rw3f4U4gzZq5jKYzCF70YtZk7eGWHTQ-34I_w5RjUtPWOE3jZjvpGjxMWHtfmSks9WrfbvBym3moV9_-6x8v12sE6-lmz8z6D4Oxob3W7nT2-EX3YXb5EzzrRe3j1oPvoy4fjz6uT5PT8Y71aniaClXRMhIwvT2XHgEgGmZC0lDKHqHmnhOSsK8u85G0rScY7lREmBe-IKNqS5QqA7aOD2Xfj7LcAfmwG7Vvoe2HABt_QskjLtCxY9n-0qFiaE86LiB7OaOus9w66ZuP0INzUUNJsc20ec43smwfbIAdQj-TfICPwdgZE65trG5yJH_IPoz9kt677</recordid><startdate>20150120</startdate><enddate>20150120</enddate><creator>Yellol, Gorakh S</creator><creator>Yellol, Jyoti G</creator><creator>Kenche, Vijaya B</creator><creator>Liu, Xiang Ming</creator><creator>Barnham, Kevin J</creator><creator>Donaire, Antonio</creator><creator>Janiak, Christoph</creator><creator>Ruiz, José</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SR</scope><scope>8BQ</scope><scope>8FD</scope><scope>JG9</scope><scope>7TK</scope></search><sort><creationdate>20150120</creationdate><title>Synthesis of 2‑Pyridyl-benzimidazole Iridium(III), Ruthenium(II), and Platinum(II) Complexes. Study of the Activity as Inhibitors of Amyloid‑β Aggregation and Neurotoxicity Evaluation</title><author>Yellol, Gorakh S ; Yellol, Jyoti G ; Kenche, Vijaya B ; Liu, Xiang Ming ; Barnham, Kevin J ; Donaire, Antonio ; Janiak, Christoph ; Ruiz, José</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a381t-ab0002bf3e0b3e5ab18bb6eab16fdab43f88684ccb054fd503ba4f0a7c836dee3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Agglomeration</topic><topic>Amyloid beta-Peptides - chemistry</topic><topic>Amyloid beta-Peptides - toxicity</topic><topic>Animals</topic><topic>Benzimidazoles - chemistry</topic><topic>Cationic</topic><topic>Chemistry Techniques, Synthetic</topic><topic>Design analysis</topic><topic>Diffraction</topic><topic>Drug Design</topic><topic>Female</topic><topic>Fluorescence</topic><topic>Iridium - chemistry</topic><topic>Ligands</topic><topic>Mice</topic><topic>Models, Molecular</topic><topic>Molecular Conformation</topic><topic>Neurons - cytology</topic><topic>Neurons - drug effects</topic><topic>Organometallic Compounds - chemical synthesis</topic><topic>Organometallic Compounds - chemistry</topic><topic>Organometallic Compounds - pharmacology</topic><topic>Peptide Fragments - chemistry</topic><topic>Peptide Fragments - toxicity</topic><topic>Platinum - chemistry</topic><topic>Pregnancy</topic><topic>Protein Multimerization - drug effects</topic><topic>Protein Structure, Secondary</topic><topic>Ruthenium - chemistry</topic><topic>Synthesis</topic><topic>Toxicity</topic><topic>Unit cell</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yellol, Gorakh S</creatorcontrib><creatorcontrib>Yellol, Jyoti G</creatorcontrib><creatorcontrib>Kenche, Vijaya B</creatorcontrib><creatorcontrib>Liu, Xiang Ming</creatorcontrib><creatorcontrib>Barnham, Kevin J</creatorcontrib><creatorcontrib>Donaire, Antonio</creatorcontrib><creatorcontrib>Janiak, Christoph</creatorcontrib><creatorcontrib>Ruiz, José</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Engineered Materials Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Materials Research Database</collection><collection>Neurosciences Abstracts</collection><jtitle>Inorganic chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yellol, Gorakh S</au><au>Yellol, Jyoti G</au><au>Kenche, Vijaya B</au><au>Liu, Xiang Ming</au><au>Barnham, Kevin J</au><au>Donaire, Antonio</au><au>Janiak, Christoph</au><au>Ruiz, José</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis of 2‑Pyridyl-benzimidazole Iridium(III), Ruthenium(II), and Platinum(II) Complexes. Study of the Activity as Inhibitors of Amyloid‑β Aggregation and Neurotoxicity Evaluation</atitle><jtitle>Inorganic chemistry</jtitle><addtitle>Inorg. Chem</addtitle><date>2015-01-20</date><risdate>2015</risdate><volume>54</volume><issue>2</issue><spage>470</spage><epage>475</epage><pages>470-475</pages><issn>0020-1669</issn><eissn>1520-510X</eissn><abstract>The design of small molecules that can target the aggregation of Aβ as potential therapeutic agents for Alzheimer’s disease is an area of study that has attracted a lot of attention recently. The novel ligand methyl 1-butyl-2-pyridyl-benzimidazole carboxylate was prepared for the synthesis of a series of new iridium(III), ruthenium(II), and platinum(II) 2-pyridyl-benzimidazole complexes. The crystal structure of the half-sandwich iridium(III) complex was established by X-ray diffraction. An arrangement of two cationic complexes in the unit cell is observed, and it seems to be organized by weak π···π interactions that are taking place between two symmetry-related benzimidazole ring systems. All new compounds inhibited aggregation of Aβ1–42 in vitro as shown by both thioflavin T fluorescence assay and transmission electron microscopy. Among them the Ir compound rescued the toxicity of Aβ1–42 in primary cortical neurons effectively.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>25409492</pmid><doi>10.1021/ic502119b</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0020-1669 |
ispartof | Inorganic chemistry, 2015-01, Vol.54 (2), p.470-475 |
issn | 0020-1669 1520-510X |
language | eng |
recordid | cdi_proquest_miscellaneous_1872828735 |
source | American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list) |
subjects | Agglomeration Amyloid beta-Peptides - chemistry Amyloid beta-Peptides - toxicity Animals Benzimidazoles - chemistry Cationic Chemistry Techniques, Synthetic Design analysis Diffraction Drug Design Female Fluorescence Iridium - chemistry Ligands Mice Models, Molecular Molecular Conformation Neurons - cytology Neurons - drug effects Organometallic Compounds - chemical synthesis Organometallic Compounds - chemistry Organometallic Compounds - pharmacology Peptide Fragments - chemistry Peptide Fragments - toxicity Platinum - chemistry Pregnancy Protein Multimerization - drug effects Protein Structure, Secondary Ruthenium - chemistry Synthesis Toxicity Unit cell |
title | Synthesis of 2‑Pyridyl-benzimidazole Iridium(III), Ruthenium(II), and Platinum(II) Complexes. Study of the Activity as Inhibitors of Amyloid‑β Aggregation and Neurotoxicity Evaluation |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T14%3A42%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20of%202%E2%80%91Pyridyl-benzimidazole%20Iridium(III),%20Ruthenium(II),%20and%20Platinum(II)%20Complexes.%20Study%20of%20the%20Activity%20as%20Inhibitors%20of%20Amyloid%E2%80%91%CE%B2%20Aggregation%20and%20Neurotoxicity%20Evaluation&rft.jtitle=Inorganic%20chemistry&rft.au=Yellol,%20Gorakh%20S&rft.date=2015-01-20&rft.volume=54&rft.issue=2&rft.spage=470&rft.epage=475&rft.pages=470-475&rft.issn=0020-1669&rft.eissn=1520-510X&rft_id=info:doi/10.1021/ic502119b&rft_dat=%3Cproquest_cross%3E1793260447%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a381t-ab0002bf3e0b3e5ab18bb6eab16fdab43f88684ccb054fd503ba4f0a7c836dee3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1793260447&rft_id=info:pmid/25409492&rfr_iscdi=true |